Epiodyne

NIH awards 6

Annual award amounts. Total $13.4M.

• Aug 14, 2023 NIH award 5UH3DA049598-03 FY2023: $1,549,446 awarded for that fiscal year; activity UH3 (OTHER_NIH); PI GEHLERT, DONALD R; recipient as written: EPIODYNE, INC., SAN FRANCISCO, CA. Novel Therapeutics for Opioid Use Di source ↗
• Mar 29, 2023 NIH award 5R44DA056336-02 FY2023: $1,488,866 awarded for that fiscal year; activity R44 (SBIR); PI GEHLERT, DONALD R; recipient as written: EPIODYNE, INC., SAN FRANCISCO, CA. Development of an oral analgesic with red source ↗
• Sep 15, 2022 NIH award 4UH3DA049598-02 FY2022: $2,594,546 awarded for that fiscal year; activity UH3 (OTHER_NIH); PI GEHLERT, DONALD R; recipient as written: EPIODYNE, INC., SAN FRANCISCO, CA. Novel Therapeutics for Opioid Use Di source ↗
• Apr 6, 2022 NIH award 1R44DA056336-01 FY2022: $1,011,134 awarded for that fiscal year; activity R44 (SBIR); PI GEHLERT, DONALD R; recipient as written: EPIODYNE, INC., SAN FRANCISCO, CA. Development of an oral analgesic with red source ↗
• Sep 23, 2019 NIH award 1UG3DA049598-01 FY2019: $6,461,202 awarded for that fiscal year; activity UG3 (OTHER_NIH); PI GEHLERT, DONALD R; recipient as written: EPIODYNE, INC., SAN FRANCISCO, CA. Novel Therapeutics for Opioid Use Di source ↗
• Aug 15, 2018 NIH award 1R43DA047723-01 FY2018: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI MEDINA, JULIO; recipient as written: EPIODYNE, INC., SAN FRANCISCO, CA. Structure-based Optimization of Novel Analgesic source ↗